Welcome to the Amprion 2026 Event Page
Please review items of interest below or explore the rest of the website.
Amprion is at MDS 2026, booth 210
Seoul, KR | Oct 4-8, 2026
Tackle challenging diagnoses with the power of biology.
PRESENTATIONS
- IDENTIFICATION OF ALPHA-SYNUCLEINPATHOLOGY IN PRIMARY TAUOPATHIES BY SEED AMPLIFICATION ASSAY
SESSION OPP3; OCTOBER 5, 12:30 PM; CONFERENCE ROOM E1, 3RD FLOOR - DETECTION OF ALPHA-SYNUCLEIN SEEDS IN SKIN SAMPLES FROM PPMI PARTICIPANTS
SESSION OPP11; OCTOBER 7, 12:30 PM, CONFERENCE ROOM E6, 3RD FLOOR
POSTERS
- 256: IDENTIFICATION OF ALPHA-SYNUCLEIN PATHOLOGY IN DEMENTIA WITH LEWY BODY PARTICIPANTS BY SEED AMPLIFICATION ASSAY
CARLY FARRIS, SENIOR SCIENTIST; SUN, OCT 4, 9:30 AM; SESSION 1, STATION 3 - 258: A HIGHLY SPECIFIC SKIN ALPHA-SYNUCLEIN SEED AMPLIFICATION ASSAY FOR SCREENING OF SYNUCLEINOPATHIES
YIHUA MA, SENIOR SCIENTIST; SUN, OCT 4, 9:30 AM; SESSION 1, STATION 3 - 896: IDENTIFICATION OF ALPHA-SYNUCLEIN PATHOLOGY IN IDIOPATHIC RAPID EYE MOVEMENT SLEEP DISORDER PARTICIPANTS BY SEED AMPLIFICATION ASSAY
CARLY FARRIS, SENIOR SCIENTIST; MON, OCT 5, 1:00 PM; SESSION 6, STATION 16 - 1008: LONGITUDINAL ALPHA-SYNUCLEIN SEED AMPLIFICATION ASSAY ANALYSIS OF PPMI PARTICIPANTS
LUIS CONCHA, PHD, DIRECTOR OF R&D; WED, OCT 7, 1:00 PM; SESSION 12, STATION 17
Scientific Paper
The Lancet Neurology
Diagnostic and prognostic value of α-synuclein seed amplification assay kinetic measures in Parkinson's disease: a longitudinal cohort study
July 1, 2025
Read MoreScientific Paper
Nature Communications
Two-step detection of Lewy body pathology via smell-function testing and CSF α-synuclein seed amplification
August 5, 2025
Read MoreScientific Paper
npj Parkinson's Disease
Phosphorylated α-synuclein in CSF and plasma does not reflect synucleinopathy
August 7, 2025
Read MoreScientific Paper
Movement Disorders
Comparison of Two α-Synuclein Seed Amplification Assays for Discrimination of Parkinson Disease and Atypical Parkinsonism
August 20, 2025
Read MoreScientific Paper
Annals of Neurology
Cognitive Performance in Early Neuronal Synuclein Disease with Hyposmia but without Motor Disability: Association with Dopamine Deficiency and Isolated Rapid Eye Movement Sleep Behavior Disorder
July 11, 2025
Read MoreScientific Paper
Journal of Neurology
Longitudinal decline in striatal DAT binding in LRRK2 Parkinson's disease: connections with CSF α-synuclein seeding activity
September 13, 2025
Read MoreScientific Paper
Movement disorders
Skin Biopsy for Phosphorylated α-Synuclein in Mild Cognitive Impairment or Dementia Due to Lewy Body Disease in a Convenience Cohort from a Subspecialty Behavioral Neurology Practice
December 9, 2025
Read MoreScientific Paper
Journal of Parkinson's Disease
Faster reaction times of CSF alpha-synuclein seed amplification assay predict the diffuse malignant subtype of Parkinson's disease at 10-year follow-up
January 29, 2026
Read MoreScientific Paper
Journal of Parkinson's Disease
Collaborative action for biomarker breakthroughs: Validating α-synuclein seed amplification assays in Parkinson's disease
March 19, 2026
Read MoreScientific Paper
Movement Disorders
Rethinking Mitochondrial Parkinson's Disease in the α-Synuclein Seed Amplification Assays Era
May 3, 2026
Read MoreScientific Paper
npj Parkinson's Disease
Clinical correlates of a negative cerebrospinal fluid α-synuclein seed amplification assay result in Parkinson’s disease
April 14, 2026
Read MoreScientific Paper
Journal of Neuropathology & Experimental Neurology
Multisite study: Predicting Lewy body disease using skin biopsy α-synuclein seed amplification assays
September 1, 2026
Read MoreScientific Paper
Neurology
Alpha-Synuclein Seed Amplification Assay in CSF, Skin, and Submandibular Gland From Incidental Lewy Body Disease and Parkinson Disease
July 28, 2026
Read MoreScientific Paper
Journal of Parkinson's Disease
Regulatory endorsement for the application of α-synuclein seed amplification assay as a susceptibility and risk biomarker for clinical trials targeting synucleinopathies
September 16, 2026
Read MoreScientific Paper
npj Parkinson's Disease
Skin α-synuclein seed amplification assay for the identification of multiple system atrophy
September 8, 2026
Read More
Get in the Know
Bring biological certainty to your diagnosis with Amprion's SAAmplify-ɑSYN Plus test. Order your shipping kits today and help move your patient beyond a probable diagnosis.
